Home » Topics » Regulatory » Patents

Patents
RSS

Selective alphav/beta3 integrin receptor antagonists from DuPont Pharmaceuticals

Aug. 27, 1998

P&G claims alpha2-adrenoceptor agonists with a wide range of potential applications

Aug. 27, 1998

Novel antiinflammatory/antiallergy agents in the pipeline at Japan Energy

Aug. 27, 1998

Pierre Fabre describes antidepressant compounds with a dual mechanism of action

Aug. 27, 1998

Allelix research into antimigraine compounds proves fruitful

Aug. 26, 1998

Pfizer discovers new treatments for atherosclerosis and related disorders

Aug. 26, 1998

Neuroprotective glutamate receptor antagonists disclosed by Warner-Lambert

Aug. 26, 1998

Dual 5-HT reuptake inhibitors/5-HT1A antagonists with potential as antidepressants

Aug. 26, 1998

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Aug. 26, 1998

TAN-2421-A1: a novel xanthine derivative with immunomodulating activity

Aug. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...